Enzo Biochem, Inc.
ENZ
$0.464
-$0.015-3.13%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -22.84M | -26.08M | 44.73M | 32.57M | 24.31M |
| Total Depreciation and Amortization | 1.32M | 1.27M | 1.48M | 1.79M | 2.15M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.76M | 6.80M | -76.36M | -77.04M | -77.43M |
| Change in Net Operating Assets | -5.12M | -8.25M | -12.06M | -1.71M | 9.32M |
| Cash from Operations | -21.88M | -26.26M | -42.21M | -44.40M | -41.66M |
| Capital Expenditure | -739.00K | -545.00K | -995.00K | -1.52M | -2.36M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.00M | -- | -- | -- | -- |
| Cash from Investing | 4.26M | -545.00K | 100.75M | 100.22M | 99.38M |
| Total Debt Issued | -- | -- | 16.28M | 23.85M | 23.85M |
| Total Debt Repaid | -3.71M | -3.72M | -20.63M | -24.90M | -24.94M |
| Issuance of Common Stock | -- | -- | 386.00K | 400.00K | 400.00K |
| Repurchase of Common Stock | -170.00K | -474.00K | -474.00K | -467.00K | -467.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -3.88M | -4.19M | -4.82M | -1.51M | -1.55M |
| Foreign Exchange rate Adjustments | 17.00K | -5.00K | -192.00K | -130.00K | -101.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -21.47M | -31.00M | 53.52M | 54.19M | 56.07M |
